WHO ICTRP trial
Exploring HMGB1/GSDMD pathway mediating the suicide mechanism of cytotoxic CD4+…
ChiCTR2400084652 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400084652 |
|---|---|
| Public title | Exploring HMGB1/GSDMD pathway mediating the suicide mechanism of cytotoxic CD4+ T lymphocytes based on protein lactylation modification and the effect of nourishing qi and nourishing yin on AIDS patients |
| Scientific title | Exploring HMGB1/GSDMD pathway mediating the suicide mechanism of cytotoxic CD4+ T lymphocytes based on protein lactylation modification and the effect of nourishing qi and nourishing yin on AIDS patients |
| Primary sponsor | Fourth Affiliated Hospital of Xinjiang Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Acquired immunodeficiency syndrome |
| Interventions | Trial group:Taiqi Peiyuan free-decocting granule (15G/time, 2 times/day) + antiretroviral treatment;Trial group:antiretroviral treatment |
| Registration date | May 22, 2024 |
| Target size | Trial group:50;Trial group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: